Exactly, thank you. PM knows UK clinical trial registry updated the new endpoints. I don't understand his demand. Who cares about the publication if the RAs bless the approval. The company has enough money to keep the lights on for a foreseeable future now. I think having sought the MHRA approval is the best course of action now and it could come any day. Go NWBO!
Market Data 
Markets 
AI
